M&A Deal Summary

SEDLine Acquires Hospira - Brain Functioning Monitoring Business

On January 12, 2010, SEDLine acquired medical products company Hospira - Brain Functioning Monitoring Business from Hospira

Acquisition Highlights
  • This is SEDLine’s 1st transaction in the Medical Products sector.
  • This is SEDLine’s 1st transaction in the United States.
  • This is SEDLine’s 1st transaction in Illinois.

M&A Deal Summary
Date 2010-01-12
Target Hospira - Brain Functioning Monitoring Business
Sector Medical Products
Buyer(s) SEDLine
Sellers(s) Hospira
Deal Type Divestiture

Target

Hospira - Brain Functioning Monitoring Business

Lake Forest, Illinois, United States
Hospira, Inc.'s Brain Functioning Monitoring Business offers neuromonitoring technologies to improve the care of patients under anesthesia or sedation.

Search 201,429 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

SEDLine

Irvine, California, United States
Category Company
Founded 2010
Sector Healthcare Services
DESCRIPTION

SEDLine, Inc.was formed with the mission to advance brain function monitoring to improve the care of patients under anesthesia or sedation. SEDLine's technology is based on 10 years of innovation that delivers proven 4-channel EEG integrated algorithm performance, demonstrated reliability under challenging clinical conditions, and superior resistance to electrocautery.

DEAL STATS #
Overall 1 of 1
Sector (Medical Products) 1 of 1
Type (Divestiture) 1 of 1
State (Illinois) 1 of 1
Country (United States) 1 of 1
Year (2010) 1 of 1

Seller(S) 1

SELLER

Hospira

Lake Forest, Illinois, United States
Category Company
Founded 2003
Sector Life Science
Employees19,000
Revenue 4.5B USD (2014)
DESCRIPTION

Hospira, Inc. is a global specialty pharmaceutical and medication delivery company dedicated to Advancing Wellness(TM). As the world leader in specialty generic injectable pharmaceuticals, Hospira offers one of the broadest portfolios of generic acute-care and oncology injectables, as well as integrated infusion therapy and medication management solutions. Through its products, Hospira helps improve the safety, cost and productivity of patient care. Hospira, Inc. is based in Lake Forest, Illinois.

DEAL STATS #
Overall 1 of 3
Sector (Medical Products) 1 of 1
Type (Divestiture) 1 of 3
State (Illinois) 1 of 1
Country (United States) 1 of 2
Year (2010) 1 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2009-12-15 Orchid s Generic Injectable Pharmaceuticals

Chennai, India

Orchid's Generic Injectable Pharmaceuticals provides injectable finished-dosage form pharmaceuticals business. As well as its generic injectable product portfolio and pipeline. Beta-lactam antibiotics represent a class of drugs with a wide spectrum of antibacterial activity.

Buy $400M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2010-01-27 Wasserburger Arzneimittelwerk

Wasserburg, Germany

Wasserburger Arzneimittelwerk GmbH is a well established contract manufacturing organisation specialised in the aseptic filling and lyophilsation of pharmaceuticals into ampoules and vials on behalf of a wide variety of customers.

Sell -
Mergr

Product

Company

Legal